Skip to main content
. 2020 Nov 9;35(9):2514–2523. doi: 10.1038/s41433-020-01250-x

Fig. 3. The FAZ in the eyes of CM patients and their contralateral healthy eyes were evaluated with OCTA.

Fig. 3

There were no significant differences in the FAZ of macular-compared affected eyes with contralateral/control eyes (0.255 ± 0.096 mm2, 0.290 ± 0.075 mm2, p = 0.411 > 0.05).